Up-regulation of the fibrogenic cytokine TGF-β1 by oxysterols:: a mechanistic link between cholesterol and atherosclerosis

被引:62
作者
Leonarduzzi, G
Sevanian, A
Sottero, B
Arkan, MC
Biasi, F
Chiarpotto, E
Basaga, H
Poli, G [1 ]
机构
[1] Univ Turin, S Luigi Gonzaga Hosp, Dept Clin & Biol Sci, I-10043 Turin, Italy
[2] Univ So Calif, Sch Pharm, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90033 USA
[3] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey
[4] CNR, Ctr Immunogenet & Expt Oncol, I-10126 Turin, Italy
关键词
7-ketocholesterol; atherogenesis; oxidized low-density lipoproteins;
D O I
10.1096/fj.00-0668fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Deposition of blood cholesterol in the subendothelial space of major arteries is a main feature of the fibrotic plaque as well as the key event in the progression of atherosclerosis. However, the mechanisms by which cholesterol triggers and sustains the fibrotic degeneration of blood arteries remain undefined. The results reported here indicate that a biologically representative mixture of oxysterols, 27-carbon products of cholesterol oxidation, rather than an individual oxysterol at the same concentration, exerts a strong profibrogenic effect when taken up by macrophages. Incubation of murine and human macrophages with such oxysterol mixture markedly promotes both expression and synthesis of one of the most potent proinflammatory and fibrogenic cytokines, transforming growth factor beta1 (TGF-beta1). By contrast, no effect on TGF-beta1 expression and synthesis was found with unoxidized cholesterol. Macrophage uptake of cholesterol and conversion to foam cells is a hallmark of early atherogenesis, but it appears that cholesterol oxidation products, as well as other low-density lipoprotein oxidation products, are required to generate a proper fibrogenic stimulus that is not fulfilled by cholesterol deposition alone.
引用
收藏
页码:1619 / +
页数:17
相关论文
共 31 条
[1]   CAPILLARY GC QUANTIFICATION OF CHOLESTEROL OXIDATION-PRODUCTS IN PLASMA-LIPOPROTEINS OF FASTED HUMANS [J].
ADDIS, PB ;
EMANUEL, HA ;
BERGMANN, SD ;
ZAVORAL, JH .
FREE RADICAL BIOLOGY AND MEDICINE, 1989, 7 (02) :179-182
[2]  
BEDOSSA P, 1995, J HEPATOL, V22, P37
[3]  
BJORKHEM I, 1988, J LIPID RES, V29, P1031
[4]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[5]  
Brooks CJW, 1983, BIOCHEM SOC T, V11, P700
[6]   Oxysterols and atherosclerosis [J].
Brown, AJ ;
Jessup, W .
ATHEROSCLEROSIS, 1999, 142 (01) :1-28
[7]   Characterization of cholesterol oxidation products formed by oxidative modification of low density lipoprotein [J].
Chang, YH ;
Abdalla, DSP ;
Sevanian, A .
FREE RADICAL BIOLOGY AND MEDICINE, 1997, 23 (02) :202-214
[8]   DETERMINATION OF CHOLESTEROL OXIDATION-PRODUCTS IN HUMAN PLASMA BY ISOTOPE-DILUTION MASS-SPECTROMETRY [J].
DZELETOVIC, S ;
BREUER, O ;
LUND, E ;
DICZFALUSY, U .
ANALYTICAL BIOCHEMISTRY, 1995, 225 (01) :73-80
[9]   STUDIES ON THE MECHANISM OF FORMATION OF 4-HYDROXYNONENAL DURING MICROSOMAL LIPID-PEROXIDATION [J].
ESTERBAUER, H ;
BENEDETTI, A ;
LANG, J ;
FULCERI, R ;
FAULER, G ;
COMPORTI, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 876 (01) :154-166
[10]   CHEMISTRY AND BIOCHEMISTRY OF 4-HYDROXYNONENAL, MALONALDEHYDE AND RELATED ALDEHYDES [J].
ESTERBAUER, H ;
SCHAUR, RJ ;
ZOLLNER, H .
FREE RADICAL BIOLOGY AND MEDICINE, 1991, 11 (01) :81-128